INTRODUCTION {#sec1}
============

Lactic acid bacteria (LAB) are a heterogeneous group of bacteria that are used in various biotechnological applications. With respect to human and animal health, many LAB are being used as mucosal delivery vehicles for therapeutic and prophylactic molecules because of their GRAS (Generally Regarded As Safe) status (Eijsink *et al*. [@bib7]), their probiotic properties and the ease with which they can be engineered to express heterologous proteins (Ouwehand *et al*. [@bib17]) to elicit an effective immune response (Lee *et al*. [@bib12]). Up to now, a definite conclusion on the best cellular location for optimal immunization, i.e. intracellular, cell wall anchored or secreted, has yet to be reported. This seems to depend on parameters such as the bacterial type, the amount and localization of the antigen, the route of administration, etc. (Wells and Mercenier [@bib28]). Many expression and secretion systems for LAB to deliver protective antigens have already been developed (Kruger *et al*. [@bib11]; Pusch *et al*. [@bib21]). Such systems require the use of expression--secretion vectors (ESVs) with a signal peptide (SP) to translocate the protein after synthesis across the bacterial cell membrane. Several SPs have been identified and incorporated into ESVs (Hols *et al*. [@bib9]; Hazebrouck, Pothelune and Azevedo [@bib8]). The secretion efficiency of different SPs seems to be host specific. For this reason, homologous SPs are thought to drive protein secretion more efficiently than heterologous SPs (Mathiesen *et al*. [@bib14]). The availability of the complete genome sequences of many *Lactobacillus casei* strains (Makarova *et al*. [@bib13]) makes it easy to search for new and efficient SPs that can be used in the construction of new ESVs for this species and maybe other lactobacilli.

In this study, putative SPs were selected from the genome of *L. casei* ATCC334 (accession no. CC000423.1) using bioinformatics analysis. The selected SPs were tested for the secretion of a gene product encoding a green fluorescent protein (GFP) as a reporter protein and using the ESV based on *Escherichia coli--L. casei* shuttle vectors previously developed in our group (Panya *et al*. [@bib19]; Suebwongsa *et al*. [@bib25]). The SP with the highest efficiency was then used to drive the secretion of a synthetic gene coding for an M2e:HBc fusion protein*.* M2e is a highly conserved protein of the influenza A virus that has been incorporated as an antigen into many influenza vaccine formulations. The immunogenicity of M2e has been reported to be enhanced when fused with the hepatitis B core antigen (HBc) (De Filette *et al*. [@bib4]). The final construct, pLC-Cwh:M2e:HBc, successfully expressed and secreted the fused antigenic protein.

MATERIALS AND METHODS {#sec2}
=====================

Bacterial strains and growth conditions {#sec2-1}
---------------------------------------

The bacterial strains, plasmid vectors and oligonucleotide primers used in this study are listed in Table [1](#tbl1){ref-type="table"}. *Lactobacillus* strains were grown statically in de Man Rogosa and Sharpe (MRS) medium (LabM, Heywood, Lancashire, UK) at 37°C. *Escherichia coli* DH5α was cultured in Luria--Bertani (LB) broth (LabM) at 37°C with shaking. Agarified media were prepared by adding 15 g l^−1^ bacteriological agar to the corresponding broth. When required, appropriate antibiotics (Sigma-Aldrich, St Louis, MO, USA) were added to the media as follows: erythromycin for *L. casei* at 2.5 μg ml^−1^, and ampicillin for *E. coli* at 100 μg ml^−1^.

###### 

Bacterial strains, plasmid vectors and oligonucleotide primers used in this study.

  Materials                 Relevant characteristics                                                                                                                    Source or reference
  ------------------------- ------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------
  Bacterial strains                                                                                                                                                     
  *E. coli* DH5α            Transformation host                                                                                                                         Taylor, Walker and McInnes *et al.* ([@bib26])
  *L. casei* RCEID02        Plasmid-free strain of *L. casei* TISTR1341 and protein expression host                                                                     RCEID
  *L. casei* ATCC334        Source of signal peptide-encoding genes                                                                                                     ATCC
  Plasmids                                                                                                                                                              
  pGEM-T Easy vector        Ap^r^, M13*ori*, T-overhang cloning vector                                                                                                  Promega
  pGFPuv                    Ap^r^, plasmid containing the GFPuv gene from *Aequorea victoria*                                                                           Clontech
  pCwh                      Ap^r^, M13*ori*, a pGEM-T-derived vector containing a promoter-less part of the *cwh* gene (*cwhSP*) encoding the Cwh signal peptide (SP)   This study
  pSur                      Ap^r^, M13*ori*, pGEM-T-derived vector containing a promoter-less part of the SurSP gene encoding SurSP signal peptide                      This study
  pSP6565                   Ap^r^, M13*ori* pGEM-T-derived vector containing a promoter-less part of the SP6565 gene encoding SP6565 signal peptide                     This study
  pCwh:GFPuv                Ap^r^, M13*ori*, pCwh derivative containing GFPuv-encoding gene downstream of *cwh* gene                                                    This study
  pSur:GFPuv                Ap^r^, M13*ori*, pSur containing GFPuv-encoding gene downstream of Sur gene                                                                 This study
  pSP6565:GFPuv             Ap^r^, M13*ori*, p6565 containing GFPuv-encoding gene downstream of 6565gene                                                                This study
  pLdh-Pro1                 Ap^r^, M13*ori* pGEM-T vector containing the promoter of the lactate dehydrogenase (Ldh) gene and transcription terminator (TT)             This study
  pLdh:Cwh:GFPuv            Ap^r^, M13*ori*, pLdh-Pro1-derived vector containing Cwh:GFPuv downstream of Ldh promoter                                                   This study
  pLdh:Sur:GFPuv            Ap^r^, M13*ori*, pLdh-Pro1-derived vector containing Sur:GFPuv downstream of Ldh promoter                                                   This study
  pLdh:SP6565:GFPuv         Ap^r^, M13*ori*, pLdh-Pro1-derived vector containing SP6565:GFPuv downstream of Ldh promoter                                                This study
  pRCEID-LC13.9             Ap^r^, Em^r^, *E. coli*--*L. casei* shuttle vector                                                                                          Panya *et al.* ([@bib19])
  pLC-GFPuv                 pRCEID-LC13.9 containing the GFPuv-encoding gene downstream of *ldh* gene promoter                                                          This study
  pLC-Cwh:GFPuv             pRCEID-LC13.9 containing a cassette expressing the fusion protein CwhSP:GFPuv from the Ldh promoter                                         This study
  pLC-Sur:GFPuv             pRCEID-LC13.9 containing gene expression cassette consisting of Ldh:SurSP:GFPuv                                                             This study
  pLC-SP6565:GFPuv          pRCEID-LC13.9 containing gene expression cassette consisting of Ldh: SP6565:GFPuv                                                           This study
  pLC-M2e:HBc               pRCEID-LC13.9 containing gene expression cassette consisting of Ldh: M2e:HBc:TT                                                             This study
  pLC-Cwh:M2e:HBc           pLC-M2e:HBc containing Cwh upstream of Ldh:M2e:HBc                                                                                          This study
  Oligonucleotide primers   Sequences (5′--3′)/(restriction site)                                                                                                       Target gene (GenBank accession no.)
  CwhSP-F                   ACGT[AAGCTT]{.ul}CATGGTAGATGCAAAGAA (*Hin*dIII)                                                                                             Signal peptidase (SP) region
  CwhSP-R                   ATTA[GGTACC]{.ul}GCACCCGATTTGTAATTG (*Kpn*I)                                                                                                of the *cwh* gene (YP_805583.1)
  SurASP-F                  GGGC[AAGCTT]{.ul}AATGAAATTCAATAAAGT (*Hin*dIII)                                                                                             Surface antigen encoding
  SurASP-R                  ATTT[GGTACC]{.ul}GCGATACTGTCGCTTGTA (*Kpn*I)                                                                                                gene (YP_805328.1)
  SP6565-F                  ACGT[AAGCTT]{.ul}TATGAAGCATTTGAGACG (*Hin*dIII)                                                                                             Surface protein 6565
  SP6565-R                  GACA[GGTACC]{.ul}ACCAACGTACCTTTTTGT (*Kpn*I)                                                                                                encoding gene (YP_806565.1)
  Cwh-ex-F                  GCCGCGG[CCCGGG]{.ul}ATGGTAGATGCAAA (*Xma*I)                                                                                                 *cwh* gene in
  Cwh-ex-R                  AACG[CCCGGG]{.ul}CCGCACCCGATTT (*Xma*I)                                                                                                     pLC-Cwh:M2e:HBc
  M13 (-40) forward         GTTTTCCCAGTCACGAC                                                                                                                           Primer for sequencing of
  M13 (-48) reverse         AGCGGATAACAATTTCACACAGGA                                                                                                                    cloned fragments in TA cloning vectors
  Ldh:M2e:HBc-F             GGGAATAAGGGCGACACGGAAATGTTG                                                                                                                 Ldh promoter and M2e:HBc
  Ldh:M2e:HBc-R             TGGTTTCTGGCAAGGTTGACAAGATTG                                                                                                                 
  M2e:HBc:TT-F              TCAGTTGAATTGTTGTCATTCTTGCCAT                                                                                                                M2e:HBc and transcription
  M2e:HBc:TT-R              GCCTGATGCGGTATTTTCTCCTTA                                                                                                                    terminator

TISTR: Thailand Institute of Scientific and Technological Research; ATCC: American Type Culture Collection; RCEID: Research and Diagnostic Center for Emerging Infectious Diseases, Khon Kaen University; Ap^r^: ampicillin resistance; Em^r^: erythromycin resistance; *Ori*: origin of replication. Underlined nucleotides show sequences in the primers to introduce restriction enzyme sites (indicated in parentheses).

DNA manipulation {#sec2-2}
----------------

All DNA manipulation procedures were performed as described by Sambrook and Russell ([@bib23]). Plasmids from *E. coli* were isolated and purified using the HiYield plasmid mini Kit (RBC Bioscience, New Taipei City, Taiwan). Plasmids from *L. casei* were extracted as described by O\'Sullivan and Klaenhammer ([@bib18]). Genomic DNA from *L. casei* was extracted using the GenElute Bacterial Genomic DNA kit (Sigma-Aldrich). PCR amplification was performed using *Taq* DNA polymerase (Invitrogen, Carlsbad, CA, USA). Amplicons were purified from agarose gels using the HiYield Gel PCR DNA Fragments Extraction kit (RBC Bioscience).

Analysis of candidate signal peptides {#sec2-3}
-------------------------------------

The nucleotide sequences of cell surface-associated proteins of *L. casei* ATCC334 were retrieved from the NCBI microbial genomes database (<http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi>). The SignalP4.1 program (<http://www.cbs.dtu.dk/services/SignalP/>) was used to predict the putative signal peptides. The likely location of the proteins was predicted with the programs PSORTb v 3.0 (<http://www.psort.org/psortb/>), SubLoc v 1.0 (<http://www.bioinfo.tsinghua.edu.cn/SubLoc/pro_predict.htm>) and Gpos-mPLoc (<http://www.csbio.sjtu.edu.cn/bioinf/Gpos-multi/>). DNA sequences encoding SPs of cell surface-associated proteins with a clear SP cleavage site and an extracellular location were selected for the construction of ESVs.

Construction of an expression--secretion vector (ESV) for GFP {#sec2-4}
-------------------------------------------------------------

To determine whether the three selected SPs (i.e. CwhSP, SurASP and SP6565) could drive heterologous protein secretion in *L. casei*, an ESV based on each of these was constructed. SP strength was analyzed using the GFPuv-encoding gene as a reporter. Sequences encoding the three SPs were amplified from genomic DNA of *L. casei* ATCC334 under the following conditions: one cycle of 95°C for 3 min; 30 cycles of 95°C for 30 s, 60°C for 30 s, 72°C for 14 s; and 72°C for 3 min. The lengths of the amplicons, CwhSP, SurASP and SP6565, were 129 bp, 105 bp and 126 bp, respectively. The *gfp*uv gene fragment, recovered as a *Kpn*I/*Spe*I-digested fragment from pGFPuv, was cloned into pCwh, pSurA and pSP6565 to generate pCwhSP:GFPuv, pSurSP:GFPuv and pSP6565:GFPuv, respectively. The Cwh:GFPuv fusion gene was obtained by double digestion of the pCwh:GFPuv with *Hin*dIII/*Spe*I and cloned into *Hin*dIII/*Spe*I-digested pLdh-Pro1, a vector containing the constitutive promoter (P~ldh~) and ribosome binding site (RBS~ldh~) of the lactate dehydrogenase gene (GenBank accession no. D12591.1), resulting in pLdh:Cwh:GFPuv. Using the same procedure, pLdh:Sur:GFPuv and pLdh:SP6565:GFPuv were also obtained. The Ldh:Cwh:GFPuv DNA fragment obtained as a *Aat*II/*Spe*I-digested pLdh:Cwh:GFPuv was cloned into *Aat*II/*Spe*I-digested pRCEID-LC13.9 resulting in pLC-Cwh:GFPuv. The same strategy was followed to obtain the recombinant ESVs containing GFPuv with SurSP and SP6556, designated as pLC-Sur:GFPuv and pLC-SP6565:GFPuv. Figure [1](#fig1){ref-type="fig"} shows the construction diagram of pLC-Cwh:GFPuv and a similar procedure was used for the generation of the pLdh:Sur:GFPuv and pLdh:SP6565:GFPuv. All three recombinant plasmids were verified by DNA sequencing (data not shown) and were independently electrotransformed into *L. casei* RCEID02. The preparation of competent cells and the electroporation protocol were as described elsewhere (Chassy and Flickinger [@bib2]).

![Diagram depicting the construction of pLC-Cwh:GFPuv.](fnw209fig1){#fig1}

Determination of the secreted GFP by measurement of fluorescence intensity {#sec2-5}
--------------------------------------------------------------------------

To determine the secretion efficiency, the fluorescence intensity of culture supernatants derived from recombinant *L. casei* RCEID02 harboring pLC-Cwh:GFP, pLC-Sur:GFP and pLC-SP6565:GFP was determined in triplicate. Cultures of the above three recombinant constructs were incubated at 37°C for 20 h with shaking at 200 rpm until an optical density of 3.0 at 600 nm (OD600) was reached. Supernatants of the cultures were harvested and the fluorescence intensity was measured with a fluorometer (Cary Eclipse, Victoria, Australia), as previously described (Wu and Chung [@bib29]). As a negative control, the culture supernatant of *L. casei* RCEID02 harboring the expression vector without signal peptide (pLC-GFPuv) was used.

Construction of recombinant *L. casei* expressing M2e:HBc fusion protein in a secreted form {#sec2-6}
-------------------------------------------------------------------------------------------

To construct the recombinant *L. casei* expressing the secreted M2e:HBc fusion protein, the CwhSP fragment with *Xma*I flanking recognition sequences was amplified using pLC-Cwh:GFP as the template. The CwhSP-coding region was inserted upstream of the M2e:HBc gene in pLC-M2e:HBc, a vector containing a gene cassette composed of the *ldh*-derived promoter, the fusion gene encoding M2e:HBc and the transcription terminator (TT) of the *Lactococcus lactis* subsp. *cremoris* amino peptidase N (*pepN*)-encoding gene (GenBank accession no. M87840.1). Figure [2](#fig2){ref-type="fig"} shows the expression cassette of pLC-Cwh:M2e:HBc. The recombinant plasmid pLC-CwhSP:M2e:HBc was verified by DNA sequencing (data not shown) and was electrotransformed into *L. casei* RCEID02. The transformants were checked for secretion of the M2e:HBc fusion protein.

![Diagram of pLC-Cwh:M2e:HBc, the expression cassette for the fusion protein M2e:HBc containing the constitutive promoter and ribosome binding site (RBS) of lactate dehydrogenase gene (*ldh*) of *L. casei* ATCC393, the Cwh signal peptide (CwhSP), M2e:HBc fusion gene and the transcription terminator (TT) of *Lactococcus lactis* subsp. *cremoris* amino peptidase N (*pepN*) gene (GenBank accession no. M87840.1).](fnw209fig2){#fig2}

Determination of the secreted M2e:HBc fusion protein by western blot analysis {#sec2-7}
-----------------------------------------------------------------------------

Transformants containing pLC-Cwh:M2e:HBc were cultured at 37°C for 20 h with shaking at 200 rpm until an OD600 of 3.0 was reached. The supernatant and cell pellet were collected. The supernatant was concentrated 10-fold using centricons with a molecular weight cut-off of 10 kDa (Pall Life Sciences, NY, USA). The total cell extract and concentrated supernatant were electrophoresed in 12% sodium dodecyl sulphate--polyacrylamide gel electrophoresis (SDS--PAGE) followed by western blotting. The M2e:HBc fusion protein on the membrane was detected with mouse anti-M2 monoclonal antibody (Abcam, Cambridge, UK) at a dilution of 1:1000. Horseradish peroxidase-conjugated goat anti-mouse IgG (Abcam) was used as a secondary antibody at a dilution of 1:10 000. The signal was developed with a chemiluminescent substrate reagent (Thermo Fisher Scientific, Rockford, IL, USA) and recorded with a digital camera (Image Quant TM LAS 4000, Uppsala, Sweden). Total cell extracts from the transformants with pLC-Cwh:M2e:HBc and those with pLC-M2e:HBc were used as positive controls for M2e:HBc expression. Supernatants from the transformants with the pLC-M2e:HBc construct and those with pRCEID-LC13.9 were used as negative controls.

RESULTS {#sec3}
=======

Selection of the candidate signal peptides {#sec3-1}
------------------------------------------

Seventy-seven deduced amino acid sequences of *L. casei* ATCC334 genes encoding cell surface-associated proteins were retrieved from the NCBI database and analyzed with the SignalP 4.1 program to predict likely SP sequences (data not shown). The program generates a parameter called the D score, which is used to discriminate signal peptide from non-signal peptide sequences. It also indicates the presumptive location of the signal peptide cleavage site. Six proteins with a D score above the cut-off value of 0.450 contained good predictions for SP sequences (Table [2](#tbl2){ref-type="table"}). The D score of these proteins and the likely cleavage sites are summarized in Table [2](#tbl2){ref-type="table"}. Cellular location of each of the six proteins were predicted using three different programs. Five, three and one of six proteins were predicted to be extracellular by Gpos-mPLoc, PSORTb and SubLoc programs, respectively. Based on this bioinformatics analysis, SPs of the proteins encoded by the ORFs YP_805583.1, YP_805328.1 and YP_806565.1 were selected. These were designated as CwhSP, SurSP and SP6565, respectively.

###### 

Main characteristics of signal peptides (SPs) from the genome of *L. casei*, as predicted from bioinformatics analysis.

                                                          Predicted signal peptide function   Predicted cellular location                                     
  ---------------------- -------------------------------- ----------------------------------- ----------------------------- --------------- ----------------- ---------------
  YP_805583.1 (CwhSP)    Cell wall-associated hydrolase   0.696                               VSA-ST                        Extracellular   Extracellular     Periplasm
  YP_805328.1 (SurSP)    Surface antigen                  0.864                               VFA-DT                        Extracellular   Extracellular     Extracellular
  YP_806565.1 (SP6565)   Cell surface protein             0.798                               VHA-DD                        Extracellular   Extracellular     Periplasm
  YP_805464.1            Cell surface protein             0.758                               VGA-TT                        Unknown         Extracellular     Periplasm
  YP_805465.1            Cell surface protein             0.834                               VLA-LQ                        Unknown         Extracellular     Periplasm
  YP_805466.1            Cell surface protein             0.777                               VFA-SE                        Unknown         Plasma membrane   Periplasm

The D cut-off value for cell surface associate protein is 0.450.

Secretion of GFPuv in recombinant *L. casei* using different SP-containing ESV {#sec3-2}
------------------------------------------------------------------------------

To determine the secretion efficiency of the selected sequences, ESVs based on each SP with the GFPuv gene as a reporter were constructed and designated pLC-Cwh:GFPuv, pLC-Sur:GFPuv and pLC-Sp665:GFP, respectively. These ESVs were independently transformed into *L. casei* RCEID02, resulting in the recombinant strains RCEID02:CwhSP, RCEID02:SurSP and RCEID02:SP6556. The fluorescence intensity of culture supernatants of these strains, and that of *L. casei* RCEID02 pLC-GFPuv (used as a negative control), was determined. The highest fluorescence intensity value was shown by the CwhSP (164.80), followed by that of SurASP (118.80) and SP6565 (113.49) (Fig. [3](#fig3){ref-type="fig"}).

![Mean fluorescence intensity (MFI) of culture supernatants from the recombinant *L. casei* RCEID02 harboring different SP-containing constructs. The supernatant from *L. casei* RCEID02 harboring pLC-GFPuv was used as a negative control.](fnw209fig3){#fig3}

Expression and secretion of the M2e:HBc fusion protein by *L. casei* RCEID02 {#sec3-3}
----------------------------------------------------------------------------

The CwhSP was selected for constructing the ESV containing the M2e:HBc fusion gene, i.e. pLC-Cwh:M2e:HBc. Western blot analysis of the supernatant from *L. casei* cells containing pLC-Cwh:M2e:HBc showed a prominent band with an apparent molecular weight of around 27.6 kDa (Fig. [4](#fig4){ref-type="fig"}, lane 6), which presumably corresponded to the expected fusion protein. The supernatant from an intermediate construct lacking CwhSP showed no band (Fig. [4](#fig4){ref-type="fig"}, lane 4). The M2e:HBc fusion protein was detected in total cell extracts of both *L. casei* carrying pLC-M2e:HBc (Fig. [4](#fig4){ref-type="fig"} lane 3) and pLC-Cwh:M2e:HBc (Fig. [4](#fig4){ref-type="fig"} lane 5). No protein band was detected in either total cell extracts (Fig. [4](#fig4){ref-type="fig"}, lane 1) or supernatant (Fig. [4](#fig4){ref-type="fig"}, lane 2) of the negative control strain.

![Western blot analysis of M2e:HBc fusion protein expressed in recombinant *L. casei* RCEID02. Lanes 1 and 2 = total cell extracts and supernatant from *L. casei* RCEID02 containing pRCEID-LC13.9; lanes 3 and 4 = total cell extracts and supernatant from *L. casei* RCEID02 containing pLC-M2e:HBc; lanes 5 and 6 = total cell extracts and supernatant from *L. casei* RCEID02 containing pLC-CwhSP:M2e:HBc.](fnw209fig4){#fig4}

DISCUSSION {#sec4}
==========

Engineered LAB strains constitute bacterial systems that may serve as alternative mucosal delivery vehicles for a variety of biomolecules (Wells and Mercenier [@bib28]). Recombinant LAB can be used as vaccine vehicles to elicit both secretory IgA and systemic antibody responses against the delivered antigen (Neutra and Kozlowski [@bib15]). In this study we constructed recombinant *L. casei* cells expressing M2e:HBc in a secreted form with the use of novel SPs derived from the *L. casei* genome. Several SPs derived from cell surface-associated proteins and secreted proteins of LAB have been identified and used to construct distinct ESVs (Wu and Chung [@bib29]; Mathiesen *et al*. [@bib14]). Of these, the SP of Usp45SP *from Lactococcus lactis* (Daniel *et al*. [@bib3]) is the most widely used heterologous SP for protein secretion in LAB species (Dieye *et al.*[@bib5a]; Mathiesen *et al*. [@bib14]). Previous studies in Gram-positive bacteria have shown that the secretion efficiency depends not only on the SP but also on the protein to be secreted and on bacterial host (Dieye *et al*. [@bib5a]; Mathiesen *et al*. [@bib14]). Nonetheless, studies on the SP functionality for heterologous protein secretion in *Lactobacillus plantarum* WCFS1 found that the homologous SPs have similar or higher secretion efficiencies than those of heterologous origin (Mathiesen *et al*. [@bib14]). Aimed to express and secrete M2e:HBc in *L. casei*, we screened for homologous SPs using a bioinformatics approach. In our hands, the best SP predictor is SignalP4.1 (Petersen *et al*. [@bib20]). This program has been successfully used to select efficient SPs from the protein pool of *L. plantarum* WCSF1 (Mathiesen *et al*. [@bib14]). The SubLoc, PSORTb and Gpos-mPLoc programs were also used to predict the localization of the proteins produced. Using these programs, three putative SPs (CwhSP, SurASP and SP6565) were selected from cell surface-associated proteins of *L. casei* ATCC334 and used for construction of ESVs with GFP as reporter protein. The reason that the SubLoc program predicts CwhSP and SP6565 as periplasmic might be due to the fact that this program uses a dataset based on that of Reinhardt and Hubbard ([@bib22]). This dataset contains a small number of sequences of both extracellular and periplasmic groups for training the neural network, which may result in a less accurate prediction. Based on these ESV constructs, it was found that all three SPs can function for GFP secretion in *L. casei* RCEID02, and that the construct using CwhSP provides the highest GFP secretion. Previous studies found that an efficient signal peptide in Gram-positive bacteria generally contains the consensus sequence Vla-X-Ala↓Ala or Ala-X-Ala↓Ala as the SP cleavage site (Nielsen *et al*. [@bib16]; Mathiesen *et al*. [@bib14]). In this study, all three selected SPs have the consensus motif Val-X-Ala at position −3 to −1 relative to the putative cleavage site. However, none of the selected SPs contained Ala at position +1. In addition, the most efficient SP, CwhSP, harbors Ser at position +1, which indicates Ala at this position is not required. CwhSP was further used to construct an ESV containing M2e:HBc. Recombinant *L. casei* carrying this construct expressed and secreted M2e:HBc successfully, demonstrating the usefulness of bioinformatics to predict and select novel SPs for *L. casei*. However, this approach does not guarantee that the SPs selected will function, since protein secretion depends on the SP itself, the genetic background of the host strain and the target protein. In addition, secretion efficiency may be affected by the extent to which protein production levels and rates are adapted to the capacity of the translocation machinery, the influence of SP sequence on mRNA stability and its translation efficiency (Mathiesen *et al*. [@bib14]). For these reasons, to maximize the production of a secreted protein in *Lactobacillus*, and before optimization and balancing of other factors, it might be worthwhile selecting an optimal SP for each individual protein.

Besides conferring only short-term immunity, a major drawback of the current influenza virus A vaccines is that they confer only short-term subtype-specific protection. Thus, keeping vaccines up-to-date with influenza A antigens requires constant monitoring of the subtypes of the circulating viruses (Johansson and Brett [@bib10]). This inconvenience has led to much discussion about the development of a universal influenza A vaccine, able to provide protection against all virus subtypes (Du, Zhou and Jiang [@bib5]). Such a vaccine would require identification of a viral component conserved through all subtypes of influenza A virus for eliciting a broad-spectrum immunity (Stanekova and Vareckova [@bib24]). The extracellular domain of the M2 protein (M2e) of the influenza virus is one such conserved component (Ebrahimi and Tebianian [@bib6]). However, this is a short peptide of only 24 amino-acid residues. In this study, the M2e-encoding gene was fused with the gene coding for the hepatitis B core antigen (HBc) protein in order to increase its immunogenicity. In a previous study, strong immunogenicity and full protection were obtained in mice after either intraperitoneal or intranasal administration of the M2e:HBc fusion protein (De Filette *et al*. [@bib4]). Considering their GRAS status, the use of *L. casei* as an antigen delivery vehicle can confer great advantage for the expression of the M2e:HBc fusion protein.

As a conclusion, in this study, we used a bioinformatics approach to select potential SPs from the *L. casei* ATCC334 genome. The three selected SPs, which include those of Cwh, SurA and 6565 proteins, proved to direct secretion of the GFP in *L. casei*. CwhSP, which showed the highest secretion efficiency, was then used to develop an ESV construct expressing and secreting the fused M2e:HBc protein. This SP and the ESV developed may further serve for the expression and secretion of a variety of homologous and heterologous proteins in *L. casei* and surely in other LAB species.
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